SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Seattle Genetics (SGEN)
An SI Board Since November 2000
Posts SubjectMarks Bans
161 32 0
Emcee:  keokalani'nui Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
61Seattle Genetics Reports on SGN-30 and SGN-40 Clinical Programs 2004-12-06 09:01mopgcw-12/7/2004
60Seattle Genetics Expands SGN-40 Clinical Program into Non- 2004-12-02 09:01 (Newmopgcw-12/3/2004
59Seattle Genetics and Genentech Expand Antibody-Drug Conjugate 2004-11-09 09:01 (mopgcw-11/15/2004
58Seattle Genetics Reports Third Quarter 2004 Financial Results 2004-10-26 16:15 (mopgcw-10/27/2004
57Curagen takes an ADC (humanized by ABGX) antibody to the clinic next year: Metuck-10/13/2004
56DNA, CRA and Applera are each ADC licensees. <i> Press Release Source: Ckeokalani'nui-9/28/2004
55Seattle Genetics Announces Antibody-Drug Conjugate Agreement with Bayer Pharmacekeokalani'nui-9/28/2004
54Seattle Genetics Initiates SGN-30 Phase II Clinical Trial for Cutaneous Lymphomanigel bates-9/23/2004
53Wachovia pt 2: Competition Other companies are developing toxin-linked antibodimopgcw-9/12/2004
52Wachovia starts coverage: SGEN: Initiating Coverage--Market Perform &#9830;mopgcw-9/12/2004
51<toying with it for a while, but have not been able to pull the trigger for skeokalani'nui-9/8/2004
50a chance to pick up some cheap shares in the $5's again or is this a real semopgcw-9/7/2004
49Resigned to take job at Zymo.keokalani'nui-9/7/2004
48Seattle Genetics Announces Douglas Williams to Step Down as Chief Scientist Tuesmopgcw-9/7/2004
47Seattle Genetics Receives Orphan Drug Designation for SGN-40 in Multiple Myelomamopgcw-8/24/2004
46Merriman starts coverage with a buy fwiw (eom)mopgcw-8/19/2004
45BoA starts coverage w/ a buy and $10 target.mopgcw-8/17/2004
44Baker buys another 78,000 shares...mopgcw-8/12/2004
43Baker boys buy a whole lot of SGEN on the open market... BAKER BIOTECH CAPITA,Dmopgcw-8/10/2004
42WRH: SOLID FUNDAMENTALS; COMPELLING VALUATION; REITERATE BUY 2004-07-28 09:05 (Nmopgcw-7/30/2004
41Seattle Genetics Initiates SGN-15 Phase II 2004-07-23 09:03 (New York) Biomarkmopgcw-7/26/2004
40Celera Genomics & Seattle Genetics Announce Collaboration to Co-Develop Targnigel bates-7/21/2004
39Seattle Genetics Establishes Preferred Antibody-Drug Conjugate Manufacturing Relmopgcw-7/13/2004
38also posted on Momo/tfif, sorry for the duplicate post, but easier for me to keemopgcw-7/6/2004
37Yes. Not bad at all. Wish they'd hurry up their next gen proprietary conjukeokalani'nui-6/22/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News